Oragenics to start probiotic mouthrinse study

By Elaine Rigoli

Tampa, Fla., June 13 - Oragenics, Inc. said it plans to start recruitment this month for a human study for its proprietary oral probiotic product, Probiora3, designed to determine the effects of the mouthrinse on oral health.

Twenty subjects will use the Probiora3 mouthrinse twice daily for one to two months, the company said in a news release.

The human mouth contains hundreds of different types of bacteria, some of which are good and some of which are bad with regard to the health of the human host. The key to maintaining good oral health is to keep the balance of bacteria in favor of the good bacteria that support healthy gums and teeth, the release said.

Probiotics is defined as the administration of live bacteria to confer a health benefit and is typically associated with products such as yogurt that contains live bacterial cultures for maintaining gut health.

Oragenics is a biopharmaceutical company based in Alachua, Fla.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.